KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) EBT: 2010-2025

Historic EBT for Exelixis (EXEL) over the last 16 years, with Oct 2025 value amounting to $252.4 million.

  • Exelixis' EBT rose 63.10% to $252.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $873.3 million, marking a year-over-year increase of 45.57%. This contributed to the annual value of $681.6 million for FY2025, which is 164.69% up from last year.
  • According to the latest figures from Q4 2025, Exelixis' EBT is $252.4 million, which was up 9.55% from $230.4 million recorded in Q3 2025.
  • Exelixis' EBT's 5-year high stood at $292.8 million during Q2 2024, with a 5-year trough of -$182.3 million in Q1 2021.
  • In the last 3 years, Exelixis' EBT had a median value of $154.8 million in 2024 and averaged $148.0 million.
  • In the last 5 years, Exelixis' EBT crashed by 335.73% in 2021 and then soared by 4,329.73% in 2022.
  • Quarterly analysis of 5 years shows Exelixis' EBT stood at $118.0 million in 2021, then plummeted by 126.63% to -$31.4 million in 2022, then spiked by 427.87% to $103.0 million in 2023, then skyrocketed by 2,559.93% to $154.8 million in 2024, then surged by 63.10% to $252.4 million in 2025.
  • Its EBT stands at $252.4 million for Q4 2025, versus $230.4 million for Q3 2025 and $205.7 million for Q2 2025.